# Progress Note 06 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Flannery O'Connor (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML046-SYN
- Date: 2026-10-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Augusta Pemberton-Diallo, MD
- Calendar frame: modern shifted

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39) with CPT 99497 (advance care planning) on the same day

## Chief complaint

Adult preventive visit; no new complaints. **S**

## History of present illness

Ms. O'Connor returns for her yearly preventive visit, five months into treatment for lupus nephritis. Her joints and skin are quiet, and the three-month results showed the urine protein falling by half. She is on prednisone 7.5 mg a day, tapering. The bladder infection in June cleared with nitrofurantoin. She writes five mornings a week and has finished a draft of her novel. She completed the health risk assessment before the visit. **S**

| Element | Detail |
|---|---|
| Visit | Adult preventive visit, age 25 |
| Active conditions | Systemic lupus erythematosus with class III lupus nephritis on treatment |
| Medicines | Mycophenolate 1000 mg twice daily; belimumab 200 mg weekly; hydroxychloroquine 300 mg daily; losartan 25 mg daily; prednisone 7.5 mg daily, tapering; vitamin D3 1000 units daily |
| Recent events | Cystitis in June, resolved |
| Functional status | Independent; no morning stiffness |

## Health risk assessment

Completed by the patient before the visit and reviewed during the visit. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good, and much better than in the spring |
| Psychosocial | Supported by friends and her writing community; feels safe; health insurance covers her medicines |
| Behavioral | Never smoker; alcohol rarely; walks most days; sunscreen and a hat outdoors |
| Activities of daily living | Independent in all |
| Instrumental activities of daily living | Manages her medicines, injections, money, and correspondence |
| Sexual and reproductive health | One long-term partner; intrauterine system in place; not planning pregnancy this year |
| Home safety | Smoke detectors working; wears a seat belt; gloves and a mask when cleaning the bird pens |
| Hearing and vision | Baseline eye examination for hydroxychloroquine in June normal; hearing normal |
| Sleep | Eight hours; less fatigue |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; weight stable after a small gain on prednisone |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Negative | No mouth ulcers |
| Cardiovascular | Negative | No chest pain or leg swelling |
| Respiratory | Negative | No cough or pleuritic pain |
| Gastrointestinal | Negative | No diarrhea or abdominal pain on mycophenolate |
| Genitourinary | Negative | No urinary symptoms; light periods with the intrauterine system |
| Musculoskeletal | Negative | No joint pain; no hip, groin, or knee pain |
| Integumentary | Negative | No rash; hair regrowing |
| Neurological | Negative | No headaches or seizures |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |

11 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for joint pain, no more than 3000 mg a day **S**
- Hydroxychloroquine sulfate 300 mg oral tablet, one tablet by mouth once daily (5 mg/kg of actual body weight), long term **S**
- Losartan potassium 25 mg oral tablet, one tablet by mouth once daily, for proteinuria and blood pressure **S**
- Prednisone 5 mg oral tablet: 30 mg (six tablets) once daily from the day after the last pulse, reduced by 5 mg every two weeks to 10 mg, then to 5 mg a day or less by six months **S**
- Mycophenolate mofetil 500 mg oral tablet, one tablet twice daily for one week, then two tablets (1000 mg) twice daily **S**
- Belimumab 200 mg/mL subcutaneous autoinjector: 400 mg (two injections) once weekly for four doses, then 200 mg once weekly **S**
- Cholecalciferol (vitamin D3) 1000 units oral tablet, one tablet by mouth once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 116/74 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 62.2 kg; BMI 22 kg/m². All vital signs are synthetic.

PHQ-2: 0; AUDIT-C: 1. All results are synthetic.

## Immunizations given today

- Influenza vaccine, 2026-2027 season **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Well-appearing; BMI 22.0 |
| Eyes | Pupils equal and reactive |
| Mouth | No ulcers; teeth in good repair |
| Neck | No nodes |
| Cardiovascular | Regular rhythm; no murmur or rub; no edema |
| Respiratory | Clear |
| Musculoskeletal | No synovitis; full, painless hip movement |
| Skin | No malar or discoid rash; no suspicious moles |
| Psychiatric | Engaged and funny |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Adult preventive visit completed**. Health risk assessment reviewed and a written prevention plan given. Depression screen negative; AUDIT-C 1. **S**
   - Next preventive visit in one year.
2. **Systemic lupus erythematosus on immunosuppression** (M32.19). Clinically quiet. Infection prevention is complete for the year with today's influenza vaccine; COVID-19 vaccine due. **S**
   - Continue the rheumatology plan; six-month assessment this month.
3. **Cervical cancer screening while immunosuppressed**. Cytology two years ago was normal. Women on immunosuppression have a higher risk of cervical precancer, so yearly screening is advised while she is on mycophenolate. **S**
   - Cervical cytology with HPV testing today; result by portal message.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Influenza vaccine, 2026-2027 | Completed today | Inactivated vaccine given today; live vaccines are avoided on immunosuppression |
| COVID-19 vaccine, 2026-2027 | Due | Recommended; booked at her pharmacy next week |
| Pneumococcal vaccine | Up to date | PCV20 in April, recommended for immunocompromised adults; no further doses |
| Recombinant zoster vaccine | Up to date | Two doses, in April and July, recommended from 19 for immunocompromised adults |
| HPV vaccine | Up to date | Series completed in adolescence |
| Hepatitis B vaccine | Up to date | Vaccinated in infancy; surface antibody positive and surface antigen negative in April |
| Tetanus booster | Up to date | Tdap seven years ago |
| Cervical cancer screening | Ordered | Cytology with HPV testing today, yearly while immunosuppressed |
| Hepatitis C and HIV screening | Up to date | Negative in April, before immunosuppression |
| Chlamydia and gonorrhea screening | Not indicated | Age 25 with one long-term partner; offered if risk changes |
| Contraception | Up to date | Levonorgestrel intrauterine system since April; required while on mycophenolate |
| Folic acid | Completed today | Advised 0.4 mg daily, as for all who could become pregnant |
| Blood pressure screening | Completed today | 116/74 mmHg on losartan |
| Cholesterol and diabetes | Up to date | LDL 128 mg/dL and HbA1c 5.3 percent in July on prednisone; no statin; recheck at one year on a low dose |
| Depression screening | Completed today | PHQ-2 score 0 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C 1, negative |
| Skin cancer prevention and sun protection | Completed today | Daily broad-spectrum sunscreen and a hat, also for lupus photosensitivity |
| Physical activity and diet counseling | Completed today | Walking most days; calcium-rich foods; low salt for blood pressure and the kidneys |

## Advance care planning

Voluntary advance care planning discussion of about 15 minutes, with her consent. She has named a close friend as her health care agent and completed a written health care directive today, now scanned into the chart. Her first instruction is that she is to be told the truth about her illness directly, and that no clinician is to give her information to anyone else before giving it to her. She would want full treatment for a lupus flare or an infection; she would not want prolonged life support if she could not expect to recover the ability to read and write. **S**

## Guideline basis

- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Cervical screening result by portal message. Six-month lupus nephritis assessment this month. COVID-19 vaccine next week. **S**
- Next scheduled visit 2026-10-26: six-month response assessment: complete renal response; prednisone 5 mg; pregnancy planning. **S**
